Cancers·Aug 27Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated CellsCohort study of 7,183 peopleBiomarkersPaper
The Oncologist·Aug 8Association of sodium-glucose co-transport protein 2 inhibitor use with clinical outcomes in patients receiving immune checkpoint inhibitors: a pan-tumor propensity-matched analysisCohort study of 1,146 peopleSGLT2 inhibitorsPaper
International Journal of Molecular Sciences·Jul 15A Dysbiosis-Urolithin A Depletion-Low 6-Sulfatoxymelatonin Triad as a Composite Biomarker Framework Across Age-Related Vascular and Malignant Disease StatesCross-sectional study of 333 peopleBiomarkersPaper
Brazilian Journal of Oncology·Jun 26Association of Handgrip Strength, Adductor Pollicis Muscle Thickness and SARC-F Questionnaire with Short- and Long-Term Survival in Patients with Advanced CancerCohort study of 87 peopleSARC-FPaper
medRxiv·Mar 9Attention-Enhanced U-Net Segmentation for Reliable Detection of Circulating Tumor-Associated CellsPreprint: cohort study of 7,183 peopleBiomarkersPaper
Cancers·Oct 28Dietary Interventions in Cancer Treatment and Response: A Comprehensive ReviewReviewCancerPaper
Drugs & Aging·Jul 17Immune Checkpoint Inhibitors for Patients Aged ≥ 75 Years with Advanced Cancer in First- and Second-Line Settings: A Meta-AnalysisReviewInterventionsPaper
Preprint·May 7Timing of immune checkpoint inhibitors for metastatic patients over 75 years of age: the earlier the betterPreprint: meta-analysis of randomized trialsImmune checkpoint inhibitorsPaper
European Journal of Cancer·Mar 7Impact of aging on immune-related adverse events generated by anti-programmed death (ligand)PD-(L)1 therapiesStudy in peoplePopulationsPaper
BMC Cancer·Sep 12Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trialTrial in peopleInterventionsPaper